Style | Citing Format |
---|---|
MLA | Moghimipour E, et al.. "Development of Propranolol Loaded Sln for Transdermal Delivery: In-Vitro Characterization and Skin Deposition Studies." Therapeutic Delivery, vol. 16, no. 3, 2025, pp. 205-215. |
APA | Moghimipour E, Khazali M, Makhmalzadeh BS, Abedini Baghbadorani M, Zangeneh A, Sohrabi S, Nejaddehbashi F, Hajipour F, Handali S (2025). Development of Propranolol Loaded Sln for Transdermal Delivery: In-Vitro Characterization and Skin Deposition Studies. Therapeutic Delivery, 16(3), 205-215. |
Chicago | Moghimipour E, Khazali M, Makhmalzadeh BS, Abedini Baghbadorani M, Zangeneh A, Sohrabi S, Nejaddehbashi F, Hajipour F, Handali S. "Development of Propranolol Loaded Sln for Transdermal Delivery: In-Vitro Characterization and Skin Deposition Studies." Therapeutic Delivery 16, no. 3 (2025): 205-215. |
Harvard | Moghimipour E et al. (2025) 'Development of Propranolol Loaded Sln for Transdermal Delivery: In-Vitro Characterization and Skin Deposition Studies', Therapeutic Delivery, 16(3), pp. 205-215. |
Vancouver | Moghimipour E, Khazali M, Makhmalzadeh BS, Abedini Baghbadorani M, Zangeneh A, Sohrabi S, et al.. Development of Propranolol Loaded Sln for Transdermal Delivery: In-Vitro Characterization and Skin Deposition Studies. Therapeutic Delivery. 2025;16(3):205-215. |
BibTex | @article{ author = {Moghimipour E and Khazali M and Makhmalzadeh BS and Abedini Baghbadorani M and Zangeneh A and Sohrabi S and Nejaddehbashi F and Hajipour F and Handali S}, title = {Development of Propranolol Loaded Sln for Transdermal Delivery: In-Vitro Characterization and Skin Deposition Studies}, journal = {Therapeutic Delivery}, volume = {16}, number = {3}, pages = {205-215}, year = {2025} } |
RIS | TY - JOUR AU - Moghimipour E AU - Khazali M AU - Makhmalzadeh BS AU - Abedini Baghbadorani M AU - Zangeneh A AU - Sohrabi S AU - Nejaddehbashi F AU - Hajipour F AU - Handali S TI - Development of Propranolol Loaded Sln for Transdermal Delivery: In-Vitro Characterization and Skin Deposition Studies JO - Therapeutic Delivery VL - 16 IS - 3 SP - 205 EP - 215 PY - 2025 ER - |